13.67
Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten
Will Denali Therapeutics Inc. stock benefit from interest rate changesFree Investment Community - jammulinksnews.com
What analysts say about Denali Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
What drives Denali Therapeutics Inc. stock priceFree Technical Analysis Support - Autocar Professional
Is Denali Therapeutics Inc. a good long term investmentOutperformance with explosive growth - jammulinksnews.com
Denali Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
What makes Denali Therapeutics Inc. stock price move sharply3x Return Stock Radar - beatles.ru
BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
When (DNLI) Moves Investors should Listen - news.stocktradersdaily.com
Denali Therapeutics' Insider Sale: Routine Diversification or a Cause for Concern? - AInvest
DNLI SEC FilingsDenali Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
FDA accepts priority review for Denali’s Hunter syndrome therapy By Investing.com - Investing.com South Africa
FDA accepts priority review for Denali’s Hunter syndrome therapy - Investing.com Australia
Stifel Nicolaus Reaffirms Their Buy Rating on Denali Therapeutics (DNLI) - The Globe and Mail
Denali Therapeutics stock gains as FDA grants priority review for Hunter syndrome drug - Investing.com Nigeria
Denali Therapeutics stock gains as FDA grants priority review for Hunter syndrome drug By Investing.com - Investing.com South Africa
Denali Therapeutics Announces FDA Acceptance and Priority - GlobeNewswire
Factor Thisâ„¢ Energy Understood. All Factored In. - FinancialContent
First Brain-Penetrating Hunter Syndrome Treatment in 20 Years Gets FDA Priority Review - Stock Titan
Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - simplywall.st
Denali Therapeutics: Navigating Through Recent Setbacks (NASDAQ:DNLI) - Seeking Alpha
(DNLI) Proactive Strategies - news.stocktradersdaily.com
Denali Therapeutics stock poised for catalyst as FDA decision nears By Investing.com - Investing.com South Africa
(DNLI) Investment Analysis - news.stocktradersdaily.com
Transcript : Denali Therapeutics Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Ameriprise Financial Inc. Has $341,000 Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World
15,100 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Acquired by Two Sigma Advisers LP - Defense World
Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report? - Yahoo Finance
Denali Therapeutics Enters Registration Rights Agreement - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):